Skip to main content

Animations

MJFF Publications

1731 - 1740 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2025
  • 2023
  • 2022
  • 2023
  • 2012
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bpj.2023.11.2100
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.086490
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub‐haplotypes
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.086923
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Comparative mapping of single‐cell transcriptomic landscapes in neurodegenerative diseases
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.70012
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Temporal landscape of mitochondrial proteostasis governed by the UPR mt
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh8228
    Citation Count: 19
  • Summary Details
    OPEN
    Title: A step forward for LRRK2 inhibitors in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374
    Citation Count: 18
  • Summary Details
    OPEN
    Title: In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00775
    Citation Count: 15
  • Summary Details
    OPEN
    Title: BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2012.84
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Towards early diagnosis and screening of Alzheimer’s disease using frequency locked whispering gallery mode microtoroids
    Journal Name: npj Biosensing
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s44328-024-00009-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adu6050
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.